These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 373096)

  • 21. Donor pretreatment: rat heart allograft survival and measurement of passenger leukocyte depletion with indium-111.
    Oluwole S; Hardy MA; Wang T; Satake K; Todd G; Reemtsma K; Nowygrod R
    Transplantation; 1980 Jul; 30(1):31-3. PubMed ID: 6994282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats.
    Motoyama K; Kamei T; Arima T; Ueki M; Hirano T; Nakafusa Y; Tanaka M
    World J Surg; 1995; 19(2):299-302. PubMed ID: 7538717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin.
    Shapira OM; Rene H; Lider O; Pfeffermann RA; Shemin RJ; Cohen IR
    J Surg Res; 1999 Jul; 85(1):83-7. PubMed ID: 10383842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a single donor-specific blood transfusion on the survival of rat cardiac allografts.
    Tanaka K; Sakagami K; Orita K
    Acta Med Okayama; 1988 Feb; 42(1):31-6. PubMed ID: 2966542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.
    Ochiai T; Nakajima K; Nagata M; Hori S; Asano T; Isono K
    Transplantation; 1987 Dec; 44(6):734-8. PubMed ID: 2447689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors determining prolongation of rat heart allograft survival by perioperative injection of donor spleen cells.
    Westra AL; Petersen AH; Wildevuur CR; Prop J
    Transplantation; 1991 Oct; 52(4):606-10. PubMed ID: 1926338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Evidence of differential immunogenicity between vascularized cardiac allografts and islets.
    Stegall MD; Tezuka K; Oluwole SF; Engelstad K; Jing MX; Andrew J; Hardy MA
    Transplantation; 1990 Feb; 49(2):246-51. PubMed ID: 2137652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplantation; 1988 Jun; 45(6):1131-5. PubMed ID: 3289153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival.
    McKenzie JL; Beard ME; Hart DN
    Transplantation; 1984 Oct; 38(4):371-6. PubMed ID: 6388063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
    Dulley FL; Vigorito AC; Aranha FJ; Sturaro D; Ruiz MA; Saboya R; Macedo MC; Da Silva RL; Chamone DA; Mehta J; Bacigalupo A; De Souza CA
    Bone Marrow Transplant; 2004 Jan; 33(1):9-13. PubMed ID: 14578930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
    Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N
    Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of rat renal allograft survival by cyclophosphamide and intravenous donor-specific antigens.
    Bramis JP; Schanzer H; Taub RN
    Eur Surg Res; 1977; 9(2):140-54. PubMed ID: 15842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
    Satwani P; Bhatia M; Garvin JH; George D; Dela Cruz F; Le Gall J; Jin Z; Schwartz J; Duffy D; van de Ven C; Foley S; Hawks R; Morris E; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):324-9. PubMed ID: 22079471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.